Elena Andretta
Download the ICS Branding Pack
Open Discussion Session 4 Open Discussion ePosters 43 Intravesical hyaluronic acid instillation in treating recurrent cystitits in women: preliminar observation.
Open Discussion Session 18 E-Poster 2 369 ANTICHOLINERGIC DRUGS IN OVERACTIVE BLADDER IN A SERIES OF MULTIPLE SCLEROSIS PATIENTS: LIGHTS AND SHADOWS
Podium Short Oral Session 26 Botulinum Toxin and the Lower Urinary Tract 470 DOES INTRAPROSTATIC INJECTION OF BOTULINUM TOXIN-A REDUCE POST-VOID RESIDUAL IN BENIGN PROSTATIC HYPERPLASIA?
Non Discussion Abstract Session 32 Non Discussion Abstracts 604 MIRABEGRON IN REFRACTORY NEUROGENIC URINARY INCONTINENCE: EXPERIENCE OF A SINGLE CENTRE
Non Discussion Poster Session 34 489 Systemic side effects mimicking a clinical relapse in multiple sclerosis patients treated with botulinum A toxin for bladder dysfunction
Non Discussion Poster Session 34 597 Treatment of vesicoureteral reflux in neurogenic bladder by endoscopic injection of bulking agents
Non Discussion Abstract Session 35 Read By Title 670 Neurogenic bladder resistant to bladder injections of botulinum toxin type A: is the new toxin Incobotulinum effective in such cases?
Non Discussion Poster Session 29 385 Severe urge-incontinence in old frail women: the brilliant results obtained with detrusorial injections of low doses of botulinum toxin
Non Discussion Abstract Session 31 Read by Title 734 PREGNANCY IN PARA-TETRAPLEGIC WOMEN: WHAT HAPPENS IN THE MANAGEMENT OF THE BLADDER?
Non Discussion Abstract Session 31 Read by Title 898 How is urodynamics carried out for the time being?
ICS Member (Expired)
Dr Elena Andretta declared on the Wednesday 13th March 2013 that they did not have any existing or known future financial relationships or affiliations to disclose (NONE).
Scientific Committee Member